openPR Logo
Press release

Sunitinib Malate Capsules Market Industry Insights, Outlook and Forecast Upto 2024

01-25-2018 12:12 PM CET | Health & Medicine

Press release from: Transparency Market Research

Sunitinib Malate Capsules Market Industry Insights, Outlook

Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST).

Report Overview @ https://www.transparencymarketresearch.com/sunitinib-malate-market.html

Sunitinib malate capsules received the U.S. FDA’s approval for use in the treatment of renal cell carcinoma and GIST on January 26, 2006. They also subsequently received approval from the European Medicine Agency in July 2006. Two years later, on April 16, 2008, the drug was approved by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA).

The aforementioned regions have thus emerged as the leading markets for sunitinib malate capsules, which are marketed by Pfizer as Sutent. Pfizer has market exclusivity over sunitinib malate capsules until 2021, which has made them an important revenue source for Pfizer, which had been losing revenue owing to the patent expiration of Lipitor in November 2011. The total sales of sunitinib malate were estimated at more than US$1 bn as of 2015.

This report examines the sales potential of sunitinib malate capsules in key regional markets such as the U.K., Japan, and the U.S. It also analyzes changes in the regulatory environment that could potentially impact the trajectory of the global sunitinib malate capsules market. Protected by patents, Sutent is expected to enjoy a healthy rise in revenue for the better part of the report’s forecast period.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12125

The increasing prevalence of pancreatic cancer is a major driver for the global sunitinib capsules market. According to the American Cancer Society, around 53,000 Americans are expected to be diagnosed with pancreatic cancer in 2016, with close to 42,000 of them expected to succumb to it. Due to the relative inaccessibility of the pancreas, detecting and removing pancreatic tumors is more difficult than other tumors. As a result, the use of sunitinib malate capsules to treat pancreatic tumors is increasing.

The increasing prevalence of pancreatic neuroendocrine tumors, in particular, is a key driver for the global sunitinib malate capsules market. Sunitinib malate was approved by the FDA in May 2011 for the treatment of pancreatic neuroendocrine tumors that have proven difficult to extract surgically or have already metastasized.

However, one of the key restraints acting against the global sunitinib malate capsules market’s growth is the high cost of Sutent. It ranks among the most expensive drugs currently being marketed, which puts it out of the reach of the average consumer in the absence of sufficient reimbursement. Moreover, studies have also shown that Sutent is associated with hepatotoxicity – a condition that can lead to liver failure and even death. Adverse cardiovascular events have also been reported during clinical trials, which could discourage adoption of the drug.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=12125<ype=S

It is estimated that the global market for sunitinib malate capsules will remain concentrated in the developed G7 countries, where the sales of the drug are currently the highest. Through the latter half of the report’s forecast period, after the expiration of the patents on Sutent, the market for sunitinib malate capsules is expected to develop rapidly in the mass volume markets of China and India. This could cause a significant shift in the overall dynamics of the global market for sunitinib malate capsules.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sunitinib Malate Capsules Market Industry Insights, Outlook and Forecast Upto 2024 here

News-ID: 917601 • Views: 158

More Releases from Transparency Market Research

Lithography Equipment Market: Study Provides In-Depth Analysis Of Automotive Flo …
TMR’s report offers a complete analysis of the global Lithography Equipment Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Lithography Equipment Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @ https://www.transparencymarketresearch.com/lithography-equipment-market.html The global Lithography Equipment Market is expected to
Automotive Lighting Market Forecast With Top Companies, Growth Factors, Classifi …
TMR’s report offers a complete analysis of the global Automotive Lighting Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Automotive Lighting Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @ https://www.transparencymarketresearch.com/automotive-lighting-market.html The global Automotive Lighting Market is expected to
Power Semiconductor Market In-Depth Analysis By Key Players, Size, Share, Trends …
TMR’s report offers a complete analysis of the global Power Semiconductor Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Power Semiconductor Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @ https://www.transparencymarketresearch.com/power-semiconductor-market.html The global Power Semiconductor Market is expected to
Photomask Market Forecast With Top Companies, Growth Factors, Classification, Re …
TMR’s report offers a complete analysis of the global Photomask Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Photomask Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @https://www.transparencymarketresearch.com/photomask-market.html The global Photomask Market is expected to show a promising CAGR

All 5 Releases


More Releases for Sunitinib

Sunitinib Drug Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Sunitinib Drug Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-sunitinib-drug-market_p103889.html   Sunitinib (marketed as Sutent by Pfizer, and previously
Sunitinib Malate Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-pharmaceuticals/sunitinib-malate-market/71802 The global market size of Sunitinib Malate is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand,
Sunitinib Malate Capsules Market Research Report | Key Trends and Opportunity An …
Global Sunitinib Malate Capsules Market: Overview Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the
Sunitinib Malate Market | Key Trends and Forecast Research Report 2024
Global Sunitinib Malate Capsules Market: Overview Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the
Sunitinib Malate Capsules Market - Global Industry Analysis 2024
Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the U.S. FDA’s approval for use
Sunitinib Malate Capsules Market grows with increasing prevalence of pancreatic …
Global Sunitinib Malate Capsules Market: Overview Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the